Portfolio (Quarterly)
Guide ↗
VR ADVISER, LLC
· CIK 0001615982| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | VOR | VOR BIOPHARMA INC | Healthcare | 1,943,766.0 | $25.4M | 1.26% | +1.4M | +288.8% | $13.08 | +7.6% |
| 22 | — | CRESCENT BIOPHARMA INC. | — | 2,133,576.0 | $25.3M | 1.25% | +746K | +53.7% | $11.86 | — |
| 23 | SEPN | SEPTERNA INC | Healthcare | 610,808.0 | $17.0M | 0.84% | — | — | $27.88 | +26.1% |
| 24 | — | SURROZEN INC | — | 632,931.0 | $14.3M | 0.71% | — | — | $22.60 | — |
| 25 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 1,379,965.0 | $14.3M | 0.70% | — | — | $10.35 | +30.9% |
| 26 | — | ARTIVA BIOTHERAPEUTICS INC | — | 1,609,569.0 | $6.9M | 0.34% | — | — | $4.29 | — |
| 27 | — | CASI PHARMACEUTICALS INC | — | 987,259.0 | $839K | 0.04% | — | — | $0.85 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%